Keyphrases
Indonesia
91%
Prostate Cancer
69%
Meta-analysis
43%
Indonesian
40%
Jakarta
35%
Kidney Transplantation
30%
Donor Nephrectomy
29%
Prostate Volume
29%
Prostate-specific Antigen
29%
Benign Prostatic Hyperplasia
28%
Metastasis
26%
Renal Cell Carcinoma
26%
Castration-resistant Prostate Cancer
24%
Systematic Meta-analysis
24%
Prostate Cancer Patients
24%
Prostate Cancer Screening
23%
Bladder Cancer
22%
Tumor
20%
Androgen Deprivation Therapy
18%
Advanced Prostate Cancer
18%
Single-center Experience
18%
General Hospital
18%
Overall Survival
17%
Prostate-specific Antigen Level
17%
Prostate Radiotherapy
17%
Retrospective Analysis
16%
Bladder
15%
Prognostic Factors
15%
Inflammation
15%
Lower Urinary Tract Symptoms
15%
Radical Prostatectomy
14%
Referral Hospital
14%
Radical Cystectomy
14%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
14%
Muscle-invasive Bladder Cancer
13%
Prostate Cancer Risk
13%
Clinical Factors
13%
Length of Stay
13%
Prostate Biopsy
13%
Learning Curve
13%
Kidney
12%
Neoadjuvant Chemotherapy
12%
Prostate Disease
12%
Upper Tract Urothelial Carcinoma
12%
Prostate Cancer Risk Calculator
12%
Peer Review
12%
Targeted Therapy
12%
Progressivity
12%
Asia-Pacific Region
12%
Rare Case Report
12%
Medicine and Dentistry
Prostate Cancer
100%
Nephrectomy
41%
Kidney Transplantation
37%
Prostate Specific Antigen
33%
Prostate Hypertrophy
32%
Neoplasm
30%
Bleeding
28%
Clear Cell Renal Cell Carcinoma
27%
Castration Resistant Prostate Cancer
27%
Living Donor
27%
Transitional Cell Carcinoma
25%
Meta-Analysis
24%
Systematic Review
24%
Prostatectomy
24%
Patient Referral
20%
Quality of Life
18%
Metastatic Carcinoma
18%
Biopsy Technique
18%
Lower Urinary Tract Symptom
15%
Bladder
15%
Malignant Neoplasm
14%
Cystectomy
14%
Diseases
14%
Adenocarcinoma
13%
Androgen Deprivation Therapy
13%
Learning Curve
13%
Magnetic Resonance Imaging
12%
Prostate Disease
12%
Protein Expression
12%
Targeted Therapy
12%
Kidney Stone
12%
Cancer
11%
Health Care Cost
11%
Bladder Cancer
11%
Partial Nephrectomy
10%
Prostate Biopsy
10%
Urology
10%
Prognostic Factor
10%
Ureter
9%
Tyrosine-Kinase Inhibitor
9%
Retroperitoneal Lymph Node Dissection
9%
Cystoscopy
9%
Muscle Invasive Bladder Cancer
9%
Kidney Tumour
9%
Histopathology
9%
Benign Prostatic Hyperplasia
9%
Steroidogenesis
8%
Laparoscopic Surgery
8%
Surgeon
8%
Recurrent Disease
8%